Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.47 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL9550487 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL7176518 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL19547603 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL571199 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL6576 | 1.00 | — | — | |
| Hexane SCHEMBL2818973 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL5594746 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL5543427 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL6552198 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA | |
| Hexane SCHEMBL16897661 | 1.00 | TSHR (0.64) | TSHRALDH1A1THRBTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240049593-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-08 | — | — | US | disclosed |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| EP-4174055-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2023-05-03 | — | — | EP | disclosed |
| EP-1858094-B1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORP (JP) | 2017-03-08 | — | — | EP | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1858094-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | Pioneer Corporation (JP) | 2007-11-21 | — | — | EP | disclosed |
| US-5441959-A | Hypotensive agents; treating congestive heart failure and glaucoma,inhibiting restenosis | MERCK & CO., INC. (US) | 1995-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | TSHR 4008/4885ALDH1A1 574/4885THRB 4047/4885 |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | CRY1, SLC1A2, CHRM1 | TSHR 1230/4885ALDH1A1 12/4885THRB 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.